eXciteOSA offers a clinically tested daytime neuromuscular electrical therapy device that reduces primary snoring and mild obstructive sleep apnea without the need for overnight machines.
Funding
Funding not disclosed
Founders
Product
Problem
Primary snoring and mild obstructive sleep apnea are caused by weak tongue muscles that collapse during sleep, leading to airway blockage, disrupted breathing, and reduced sleep quality. Traditional treatments often require overnight devices such as CPAP or oral appliances, which can be uncomfortable, costly, and inconvenient for many patients.
Solution
eXciteOSA provides a clinically tested, daytime neuromuscular electrical stimulation (NMES) device that strengthens tongue muscles through brief, daily 20‑minute sessions. Users place a medical‑grade silicone mouthpiece around the tongue, and the device delivers gentle electrical pulses to improve muscle endurance and airway tone. An accompanying mobile app guides users, tracks stimulation intensity, and sends reminders to ensure consistent therapy. After approximately six weeks of regular use, the retrained tongue maintains a more open airway during sleep, reducing snoring intensity and apnea events without the need for overnight equipment. The therapy is offered with a 90‑night risk‑free trial and can be purchased directly for a monthly subscription or via HSA/FSA.
Target Audience
Primary customers are adults with primary snoring or mild obstructive sleep apnea who seek a non‑invasive, daytime alternative to CPAP or oral appliances, as well as their bed partners who are affected by snoring.
Features
- Handheld NMES device with a silicone mouthpiece that delivers targeted electrical stimulation to tongue muscles
- Daily 20‑minute therapy sessions performed at home, work, or on the go
- Mobile app for real‑time intensity control, personalized guidance, and adherence reminders
- Clinically validated outcomes: 90% of users see reduced apnea severity and 89% of bed partners notice quieter snoring
- 90‑night money‑back guarantee to reduce purchase risk
- Prescription‑based ordering workflow with rapid approval and shipping